Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease. Comparison of Outcomes With Cardiac Surgery and Paclitaxel-Eluting Stents

Journal of the American College of Cardiology

Volumn 55, Issue 11, 2010, Pages 1067-1075

  Banning, Adrian P ^a   Westaby, Stephen ^a   Morice, Marie Claude ^b   Kappetein, A Pieter ^c   Mohr, Friedrich W ^d   Berti, Sergio ^e   Glauber, Mattia ^e   Kellett, Mirle A ^f   Kramer, Robert S ^f   Leadley, Katrin ^g   Dawkins, Keith D ^g   Serruys, Patrick W ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b INSTITUT HOSPITALIER JACQUES CARTIER   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^f MAINE MEDICAL CENTER   (United States)

^g BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

coronary artery bypass grafting; diabetes; drug eluting stent; multivessel; paclitaxel

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; PACLITAXEL; THIENOPYRIDINE DERIVATIVE; TIROFIBAN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DIET THERAPY; DRUG ELUTING STENT; FEMALE; GRAFT OCCLUSION; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RISK ASSESSMENT; STENT THROMBOSIS; THERAPY EFFECT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 77649205075     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.057     Document Type: Article

References (28)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Garcia M.J., McNamara P.M., Gordon T., and Kannel W.B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23 (1974) 105-111
3. Stein B., Weintraub W.S., Gebhart S.S.P., et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91 (1995) 979-989
4. Elezi S., Kastrati A., Pache J., et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32 (1998) 1866-1873
5. Stettler C., Allemann S., Wandel S., et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. Br Med J 337 (2008) a1331
6. Mack M.J., Prince S.L., Herbert M., et al. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting. Ann Thorac Surg 86 (2008) 496-503
7. Lee M.S., Jamal F., Kedia G., et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol 123 (2007) 34-42
8. Daemen J., Kuck K.H., Macaya C., et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 52 (2008) 1957-1967
9. Park D.-W., Yun S.-C., Lee S.-W., et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 117 (2008) 2079-2086
10. Yang J.H., Gwon H.-C., Cho S.J., et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg 85 (2008) 65-70
11. Javaid A., Steinberg D.H., Buch A.N., et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 116 (2007) I200-I206
12. Kirtane A.J., Ellis S.G., Dawkins K., et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol 51 (2008) 708-715
13. Ong A.T., Serruys P.W., Mohr F.W., et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151 (2006) 1194-1204
14. Serruys P.W., Morice M.-C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
15. Lasala J.M., Cox D.A., Morris D.L., et al. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program. Am J Cardiol 103 (2009) 1663-1671
16. Mahmud E., Ormiston J.A., Turco M.A., et al. TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program. J Am Coll Cardiol Intv 2 (2009) 240-252
17. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96 (1997) 1761-1769
18. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Euro Interv 1 (2005) 219-227
19. Hannan E.L., Racz M., Holmes D.R., et al. Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents. Circulation 117 (2008) 2071-2078
20. Sheiban I., Garrone P., Sillano D., et al. Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease. J Cardiovasc Med 9 (2008) 1246-1253
21. Fleiss J., Levin B., and Paik M. Statistical Methods for Rates and Proportions. 3rd edition (2004), Wiley & Sons, Hoboken, NJ 298
22. Kimura M., Mintz G.S., Weissman N.J., et al. Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus. Am J Cardiol 101 (2008) 1263-1268
23. Kapur A., Hall R.J., Malik I.S., et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients: 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol (2009 Nov 25) [E-pub ahead of print]
24. The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49 (2007) 1600-1606
25. Frye R.L., August P., Brooks M.M., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360 (2009) 2503-2515
26. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
27. Parsonnet V., Dean D., and Bernstein A.D. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79 (1989) I3-I12
28. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497